The CLIA-lab test marks HistoIndex’s expansion from research to routine diagnostics, offering AI-based digital pathology for quantitative liver fibrosis assessment in patients with MASH.
The laboratory reports a 68% increase in one-day turnaround times within weeks of deploying the software platform.
The expansion adds compatibility with Roche’s VENTANA DP 200 and DP 600 scanners and makes AISight Dx the first digital pathology image management system cleared under the FDA’s Predetermined Change Control Plan.
Proscia is scaling its AI-powered Concentriq pathology platform, driving adoption through a variety of clinical and business benefits.
Stellaris is designed to significantly improve how scientists are able to capture three-dimensional images of living cells and tissues.
Techcyte and Pramana are launching a smart, inline volumetric digital scanning technology that integrates real-time AI analysis.